HTRF Human Total CDK1 Detection Kit
Simple, all-in-one kit for robust detection of Total CDK1
The Total CDK12 kit is designed to monitor the expression level of cellular CDK12 (Cyclin-Dependent Kinase 12).
The Total CDK12 cellular assay monitors CDK12 protein levels.
CDK12 is a transcription-associated CDK. It complexes with cyclin K to regulate gene transcription elongation via the phosphorylation of RNA polymerase II (RNAP II), and also regulates translation.
Moreover, CDK12 plays a role in RNA splicing, cell cycle progression, cell proliferation, DNA damage response (DDR), and the maintenance of genomic stability. Since the mutation or amplification of CDK12 is closely related with tumorigenesis, CDK12 has become an attractive therapeutic target for cancer treatments.
The Total CDK12 assay quantifies the expression level of CDK12 in a cell lysate. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The Total CDK12 assay uses two labeled antibodies, one coupled to a donor fluorophore and the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In the presence of CDK12 in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the protein's expression under a no-wash assay format.
The two-plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before the addition of Total CDK12 HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.
Detection of Total CDK12 with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
HeLa cells were plated in 96-well plates (50,000 cells/well) and cultured for 24h. The cells were then transfected with siRNAs specific for CDK1, CDK2, CDK4, CDK6, CDK7, CDK9, or CDK12, as well as with a negative control siRNA. After a 48h incubation, the cells were lyzed and 16 µL of lysates were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF Total CDK12 detection antibodies. An additional 4 µL of lysates (supplemented with 12 µL diluent #11) was also transferred into the microplate to monitor GAPDH level using the GAPDH Housekeeping Cellular Kit (64GAPDHPET/G/H). HTRF signals for both kits were recorded after an overnight incubation.
Cell transfection with CDK12 siRNA led to a 90% signal decrease compared to the cells transfected with the negative siRNA. No signal decrease was observed for cells transfected with CDK1, CDK2, CDK4, CDK6, CDK7, or CDK9 siRNAs. The level of GAPDH measured remained unchanged under all the conditions tested. The data demonstrate that the HTRF Total CDK12 is specific for the detection of CDK12 protein and does not cross-react with other CDK family members.
Various cell lines, either adherent HeLa, HEK293, SHSY5Y cells or suspension, such as K562 cells, were seeded at 200,000 cells / well in a 96-well microplate. After a 24H incubation, the cells were lyzed with supplemented lysis buffer, and 16 µL of lysate were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF Total CDK12 detection reagents. The HTRF signal was recorded after an overnight incubation.
HeLa cells were seeded in a 96-well culture-treated plate under 200,000 cells / well in complete culture medium, and incubated for 6H at 37 ° C, 5% CO2. The cells were then treated with Vehicle (DMSO), CDK12 Protac (BSJ-4-116), CDK12 Binder (THZ531), CRBN Binder (Thalidomide), or an Irrelevant Protac at 100 nM for 16H at 37°C, 5% C02. After cell lysis with 50 µL of supplemented lysis buffer #2, the same lysate was sequentially dispensed into a low volume detection white plate: 16 µL for Total CDK12 and an additional 4 µL (supplemented with 12 µL diluent #11) to check GAPDH levels using the HTRF GAPDH Housekeeping kit (64GAPDHPET/G/H). The corresponding kit detection reagents were added under 4 µL, and HTRF signals were recorded after an overnight incubation. The CDK12 Protac (BSJ-4-116) induced CDK12 protein degradation with an 82% signal decrease compared to the cells treated with Vehicle (DMSO). No signal decrease was observed for cells treated with CDK12 Binder, CRBN Binder, or an Irrelevant Protac. The level of GAPDH measured remained unchanged under all the conditions tested (no cytotoxicity).
HeLa and K562 cells were seeded in a 96-well culture-treated plate under 200,000 cells / well in complete culture medium, and incubated for 6H at 37 ° C, 5% CO2. The cells were then treated with increasing concentrations of CDK12 Protac (BSJ-4-116) for 16H at 37°C-5%CO2. After cell lysis, the same lysate was sequentially dispensed into a low volume detection white plate: 16 µL for Total CDK12 and an additional 4 µL (supplemented with 12 µL diluent #11) to check GAPDH levels using the HTRF GAPDH Housekeeping kit (64GAPDHPET/G/H). The corresponding kit detection reagents were added under 4 µL and HTRF signals were recorded after an overnight incubation.
As expected, the results obtained show a dose-response degradation of Total CDK12 in HeLa and K562 cells after treatment with CDK12 Protac (half maximal degradation of 40 nM and 58nM respectively), while the level of GAPDH remained constant.
K562 cells were cultured in a T175 flask in complete culture medium at 37°C-5% CO2. After a 48h incubation, the cells were lysed with 3 mL of supplemented lysis buffer #2(1X) for 30 minutes at RT under gentle shaking.
Serial dilutions of the cell lysate were performed using supplemented lysis buffer, and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF total CDK12 detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot.
Using the HTRF total CDK12 assay, 1200 cells/well were enough to detect a significant signal, while 3600 cells were needed using Western Blot with an ECL detection. Therefore in these conditions, the HTRF total CDK12 assay is 3 times more sensitive than the Western Blot technique.
CDKs are traditionally separated into 2 subfamily members: CDKs that coordinate cell cycle progression (CDK1, CDK2, CDK4, and CDK6) and transcriptional CDKS (CDK7, CDK8, CDK9, CDK12, and CDK13).
CDK12 (cyclin dependant kinase 12) forms a complex with cyclin K that regulates phosphorylation of the C-terminal domain (CTD) of RNA polymerase II. CDK12 regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability.
Physiologically relevant results fo fast flowing research - Flyers
Insider Tips for successful sample treatment - Technical Notes
HTRF and WB compatible guidelines - Technical Notes
Protocol for tumor xenograft analysis with HTRF - Technical Notes
Mastering the art of cell signaling assays optimization - Guides
Multi-tissue cellular modeling and anlysis of insulin signaling - Posters
A solution for phospho-protein analysis in metabolic disorders - Posters
Detailed protocol and direct comparison with WB - Posters
A single technology for 2D cells, 3D cells, and xenograft models - Posters
PI3K/AKT/mTor translational control pathway - Posters
Analysis of a large panel of diverse biological samples and cellular models - Posters
One technology across all samples - Application Notes
Tumor xenograft analysis: HTRF versus Western blot - Application Notes
Valuable guidelines for efficiently analyzing and interpreting results - Application Notes
Increased flexibility of phospho-assays - Application Notes
Analyse of PI3K/AKT/mTor translational control pathway - Application Notes
In collaboration with Bayer - Scientific Presentations
A fun video introducing you to phosphorylation assays with HTRF - Videos
Seeding and lysing recommendations for a number of cell culture vessels. - Technical Notes
Combination of AlphaLISA®, HTRF®, or AlphaLISA® SureFire® Ultra™ immunoassays with the ATPlite™ 1step cell viability assay - Application Notes
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.Let's find your reader